• Carcinoma in situ, bladder
  • Rapid Plasma Reagin (RPR), CSF
  • Interleukin 2 (IL2) Soluble Receptor Alpha
  • Interstitial lung disease
  • Renin Activity
  • Lamotrigine, Serum
  • ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
  • Albumin Creatinine Ratio
  • Lung Cancer, ROS1 (6q22) Rearrangement, FISH, Tissue
  • Respiratory Viral Pathogen Panel, Molecular
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Synovial Sarcoma Gene Mutation Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Synovial Sarcoma Gene Mutation Panel, NGS
Medical Test

Clinical Utility
Access to Synovial Sarcoma Gene Mutation Panel, NGS is restricted.